Saettone G P, Cazzani E, Romanò M, Muzio L
Minerva Med. 1983 Oct 6;74(38):2237-40.
25 patients with essential arterial hypertension were treated with single daily doses of 400 g acebutolol administered for EIGHT weeks in outpatients' departments. The drug proved to be extremely effective in reducing PAS and PAD values in both lying and standing positions. No undesirable side effects were observed except in one case where cardiac insufficiency was controlled by digitalis. It can therefore be concluded that acebutolol is a beta-adrenolytic drug which is reliably effective in the treatment of essential arterial hypertension, well tolerated and easily administered.
25例原发性高血压患者在门诊接受治疗，每日单次服用400克醋丁洛尔，持续八周。结果证明，该药物在降低卧位和立位时的收缩压和舒张压值方面极为有效。除1例心力衰竭患者用地高辛控制外，未观察到不良副作用。因此可以得出结论，醋丁洛尔是一种β-肾上腺素能阻断药，在治疗原发性高血压方面疗效可靠，耐受性良好且易于给药。
